VERFAHREN ZUR BEHANDLUNG ODER PRÄVENTION EINER PROTEOPATHIE

European patent · EP3307742 · In force

Register entry

Publication number
EP3307742
Application number
EP16808401
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 10, 2016
Published
Apr 18, 2018
Granted
May 18, 2022
Protection ends at the latest
Jun 9, 2036
Next annual fee due
Jun 30, 2027
IPC classes
A61K 31/5025 (2006.01)
A61K 31/5377 (2006.01)
A61K 31/541 (2006.01)
A61K 31/551 (2006.01)
A61P 25/28 (2006.01)
C07D 487/04 (2006.01)
C07D 495/04 (2006.01)
Priority
US 201562174332 P 11.06.2015
US 201562174338 P 11.06.2015
PCT application
PCT/US2016/036945 10.06.2016
PCT publication
WO2016/201266 15.12.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 4, 2024

    Change

    Published in Swissreg on 04.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Mar 29, 2023

    Change

    Published in Swissreg on 29.03.2023

  6. Jul 2, 2022

    Change

    Published in Swissreg on 02.07.2022

  7. May 18, 2022

    Granted

    Published in Swissreg on 18.05.2022

Parties

Holder

Usher III Initiative, Inc.

191 North Wacker Drive, Suite 2090, Chicago, Illinois 60606, US

Inventor

SAPERSTEIN, David

Seattle, Washington 98105, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.